The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $56.05

Today's change-0.23 -0.41%
Updated January 18 1:17 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $56.05

Today's change-0.23 -0.41%
Updated January 18 1:17 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$0.23

Bristol-Myers Squibb Co is lower today, dropping (U.S.)$0.23 or 0.41% to (U.S.)$56.05. Over the last five days, shares have lost 1.32% and 10.72% over the last 52 weeks. This security has underperformed the S&P 500 by 31.31% during the last year.

Key company metrics

  • Open(U.S.) $56.51
  • Previous close(U.S.) $56.28
  • High(U.S.) $56.55
  • Low(U.S.) $55.89
  • Bid / Ask(U.S.) $56.04 / (U.S.) $56.05
  • YTD % change-4.09%
  • Volume3,020,721
  • Average volume (10-day)9,521,107
  • Average volume (1-month)8,414,602
  • Average volume (3-month)11,335,811
  • 52-week range(U.S.) $49.03 to (U.S.) $77.12
  • Beta1.02
  • Trailing P/E27.92×
  • P/E 1 year forward19.67×
  • Forward PEG1.13×
  • Indicated annual dividend(U.S.) $1.56
  • Dividend yield2.78%
  • Trailing EPS(U.S.) $2.01
Updated January 18 1:17 PM EST. Delayed by at least 15 minutes.
S&P TSX0.12%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue4,9224,8714,3914,287
Total other revenue--------
Total revenue4,9224,8714,3914,287
Gross profit3,6173,6693,3433,345
Total cost of revenue1,3051,2021,048942
Total operating expense3,3693,2102,7414,582
Selling / general / administrative1,1441,2381,0681,501
Research & development1,1381,2661,1361,756
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-60-329-257383
Other operating expenses, total-158-167-254--
Operating income1,5531,6611,650-295
Interest income (expense), net non-operating-42-42-43-43
Gain (loss) on sale of assets-------174
Other--------
Income before tax1,5591,6151,655-410
Income after tax1,2151,1881,206-188
Income tax, total344427449-222
Net income1,2021,1661,195-197
Total adjustments to net income--------
Net income before extra. items1,2021,1661,195-197
Minority interest-13-22-11-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2021,1661,195-197
Inc. avail. to common incl. extra. items1,2021,1661,195-197
Diluted net income1,2091,1661,195-197
Dilution adjustment7------
Diluted weighted average shares1,6791,6791,6801,670
Diluted EPS excluding extraordinary itemsvalue per share0.720.690.71-0.12
Dividends per sharevalue per share0.380.380.380.38
Diluted normalized EPSvalue per share0.690.550.600.13